These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8444088)

  • 1. Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis Trialists.
    Blum AL; Adami B; Bouzo MH; Brandstätter G; Fumagalli I; Galmiche JP; Hebbeln H; Hentschel E; Hüttemann W; SChütz E
    Dig Dis Sci; 1993 Mar; 38(3):551-60. PubMed ID: 8444088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug.
    Tytgat GN; Anker Hansen OJ; Carling L; de Groot GH; Geldof H; Glise H; Efskind P; Elsborg L; Karvonen AL; Ohlin B
    Scand J Gastroenterol; 1992; 27(3):175-83. PubMed ID: 1502478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healing and prevention of relapse of reflux oesophagitis by cisapride.
    Toussaint J; Gossuin A; Deruyttere M; Hublé F; Devis G
    Gut; 1991 Nov; 32(11):1280-5. PubMed ID: 1752455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance therapy with cisapride after healing of erosive oesophagitis: a double-blind placebo-controlled trial.
    McDougall NI; Watson RG; Collins JS; McFarland RJ; Love AH
    Aliment Pharmacol Ther; 1997 Jun; 11(3):487-95. PubMed ID: 9218071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease.
    Hatlebakk JG; Johnsson F; Vilien M; Carling L; Wetterhus S; Thøgersen T
    Scand J Gastroenterol; 1997 Nov; 32(11):1100-6. PubMed ID: 9399390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and prevention of relapse of mild oesophagitis with omeprazole and cisapride: comparison of two strategies.
    Kimmig JM
    Aliment Pharmacol Ther; 1995 Jun; 9(3):281-6. PubMed ID: 7654890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
    McKenna CJ; Mills JG; Goodwin C; Wood JR
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sucralfate maintenance therapy in reflux esophagitis. Sucralfate Investigational Working Team.
    Tytgat GN; Koelz HR; Vosmaer GD
    Am J Gastroenterol; 1995 Aug; 90(8):1233-7. PubMed ID: 7639221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis.
    Galmiche JP; Fraitag B; Filoche B; Evreux M; Vitaux J; Zeitoun P; Fournet J; Soule JC
    Dig Dis Sci; 1990 May; 35(5):649-55. PubMed ID: 2331957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial.
    Galmiche JP; Brandstätter G; Evreux M; Hentschel E; Kerstan E; Kratochvil P; Reichel W; Schütze K; Soule JC; Vitaux J
    Gut; 1988 May; 29(5):675-81. PubMed ID: 3294124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisapride in the treatment of gastro-oesophageal reflux disease.
    Robertson CS; Evans DF; Ledingham SJ; Atkinson M
    Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial.
    Baldi F; Bianchi Porro G; Dobrilla G; Iascone C; Lobello R; Marzio L; Sabbatini F; Tittobello A; Verme G
    J Clin Gastroenterol; 1988 Dec; 10(6):614-8. PubMed ID: 3068300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two different dose regimens of cisapride in the treatment of reflux oesophagitis: a double-blind comparison with ranitidine.
    Geldof H; Hazelhoff B; Otten MH
    Aliment Pharmacol Ther; 1993 Aug; 7(4):409-15. PubMed ID: 8218755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
    N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride].
    Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I
    An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study.
    Richter JE; Long JF
    Am J Gastroenterol; 1995 Mar; 90(3):423-30. PubMed ID: 7872282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of relapse in reflux esophagitis: a placebo controlled study of ranitidine 150 mg bid and 300 mg bid.
    Hegarty JH; Halvorsen L; Hazenberg BP; Nowak A; Smith CL; Thomson AB; Vantrappen G; McKenna CJ; Mills JG
    Can J Gastroenterol; 1997; 11(1):83-8. PubMed ID: 9113805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healing of grade-II and III oesophagitis through motility stimulation with cisapride.
    Lepoutre L; Van der Spek P; Vanderlinden I; Bollen J; Laukens P
    Digestion; 1990; 45(2):109-14. PubMed ID: 2190850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisapride versus ranitidine in the treatment of reflux esophagitis.
    Janisch HD; Hüttemann W; Bouzo MH
    Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisapride versus ranitidine in reflux esophagitis].
    Janisch HD
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():67-9; discussion 77-8. PubMed ID: 2192508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.